- Home
- SYBX vs JFU Comparison
SYBX vs JFU Comparison
Compare SYBX & JFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYBX
- JFU
- Stock Information
- Founded
- SYBX N/A
- JFU 2006
- Country
- SYBX United States
- JFU China
- Employees
- SYBX N/A
- JFU N/A
- Industry
- SYBX Biotechnology: Pharmaceutical Preparations
- JFU Finance: Consumer Services
- Sector
- SYBX Health Care
- JFU Finance
- Exchange
- SYBX Nasdaq
- JFU Nasdaq
- Market Cap
- SYBX 16.4M
- JFU 17.1M
- IPO Year
- SYBX N/A
- JFU 2019
- Fundamental
- Price
- SYBX N/A
- JFU N/A
- Analyst Decision
- SYBX
- JFU
- Analyst Count
- SYBX 0
- JFU 0
- Target Price
- SYBX N/A
- JFU N/A
- AVG Volume (30 Days)
- SYBX 17.3K
- JFU 6.0K
- Earning Date
- SYBX 11-11-2025
- JFU 12-09-2022
- Dividend Yield
- SYBX N/A
- JFU N/A
- EPS Growth
- SYBX N/A
- JFU 3110.57
- EPS
- SYBX N/A
- JFU 3.04
- Revenue
- SYBX N/A
- JFU $44,573,690.00
- Revenue This Year
- SYBX N/A
- JFU N/A
- Revenue Next Year
- SYBX N/A
- JFU N/A
- P/E Ratio
- SYBX N/A
- JFU $0.89
- Revenue Growth
- SYBX N/A
- JFU 8.19
- 52 Week Low
- SYBX $0.90
- JFU $1.01
- 52 Week High
- SYBX $1.96
- JFU $3.25
- Technical
- Relative Strength Index (RSI)
- SYBX 57.52
- JFU 67.49
- Support Level
- SYBX $1.61
- JFU $2.58
- Resistance Level
- SYBX $1.74
- JFU $2.83
- Average True Range (ATR)
- SYBX 0.07
- JFU 0.13
- MACD
- SYBX -0.01
- JFU -0.01
- Stochastic Oscillator
- SYBX 50.00
- JFU 84.60
About SYBX Synlogic Inc.
Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.
About JFU 9F Inc.
9F Inc is a financial account platform integrating and personalizing financial services in China. It provides a range of financial products and services across online lending, wealth management, and payment facilitation, all integrated under a single digital financial account. The company generates the majority of its revenue from Loan facilitation services. All its revenues are generated from the People's Republic of China.